September 30th 2024
The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.
Win-win: How retail pharmacists can help health plans with CMS Star Ratings measures
October 10th 2014Health plans that have not scored at least three stars for the last three consecutive years will be vulnerable to elimination from the Medicare system. Pharmacists are in an ideal position to help with those scores.
FDA approves tiotropium bromide mist for COPD
September 25th 2014FDA approved tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim Pharmaceuticals) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and to reduce exacerbations in patients with COPD.
Project IMPACT: Diabetes shows value of pharmacist patient care services
September 23rd 2014Pharmacists delivering patient care services as part of patient-centered, interdisciplinary healthcare teams can make a difference for diabetes patients who are disproportionately affected by the disease and have limited access to quality care, according to the final results of Project IMPACT: Diabetes.
FDA approves once-weekly GLP-1 receptor agonist for type 2 diabetes
September 19th 2014FDA has approved dulaglutide (Trulicity, Eli Lilly) to treat type 2 diabetes mellitus. The drug is a once-weekly subcutaneous injection used to improve glycemic control and is indicated as an adjunct to diet and exercise in the management of type 2 diabetes in adults.
Buprenorphine tops list for pediatric poisoning requiring hospitalization
September 16th 2014Researchers from the Centers for Disease Control and Prevention (CDC) and FDA undertook a study to determine the most commonly implicated active ingredients responsible for childhood poisonings that required emergency hospitalization in the hope of identifying prevention and intervention strategies. Buprenorphine and clonidine were the most common of 12 active ingredients that were found in 45.0% of these hospitalizations.
Home infusion bill would benefit seriously ill Medicare patients
September 12th 2014Proposed legislation that would cover home-based infusion therapy for Medicare beneficiaries could save the healthcare system approximately $80 million over 10 years and provide access to life-saving care at patients’ homes. The potential savings is outlined in a report released in June by Avalere.